Last reviewed · How we verify
restrictive fluid administration
At a glance
| Generic name | restrictive fluid administration |
|---|---|
| Also known as | restrictive, experimental, low volume |
| Sponsor | Tel-Aviv Sourasky Medical Center |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Acupuncture for Colorectal sUrgery Recovery Enhancement: A Randomized Controlled Trial Evaluating Gastrointestinal Functional Recovery After Minimally Invasive Resection (NA)
- Enhanced Recovery After Surgery (ERAS) in Patients With Peritoneal Carcinomatosis Undergoing Cytoreductive Surgery With or Without HIPEC (NA)
- Effect of Liberal and Restrictive IV Fluids on Recovery After Gallbladder Surgery (PHASE1)
- Efficacy of Liberal Versus Restricted IV Fluid Approach in the Management of Sickle Cell Vaso-Occlusive Crisis (NA)
- Restrictive vs Liberal Intraoperative Fluid Strategy and Postoperative Outcomes After Elective Cesarean Section (NA)
- Optimized Strict Fluid Management Helps Improve Endpoints After Liver Dissection (NA)
- Restrictive Fluid Management In Liver Transplantation (REFIL) (NA)
- Ultrasound Evaluation of Preventive Measures for Postoperative Lung Atelectasis After Surgery (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- restrictive fluid administration CI brief — competitive landscape report
- restrictive fluid administration updates RSS · CI watch RSS
- Tel-Aviv Sourasky Medical Center portfolio CI